Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NeuronesXPAR:NRO -0.65%98 Debt-to-Equity is 0.09 as of Dec. 2025, which is 18% below its 10-year median of 0.11. GuruFocus rates XPAR:NRO with a GF Score™ of 98/100 and a GF Value™ of €50.62 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 2,246 Software companies, Neurones ranks better than 67.32% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Neurones's Debt-to-Equity or its related term are showing as below:
XPAR:NRO'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.11 Max: 0.12
Current: 0.09
During the past 13 years, the highest Debt-to-Equity Ratio of Neurones was 0.12. The lowest was 0.00. And the median was 0.11.
XPAR:NRO's Debt-to-Equity is ranked better than 67.32% of 2246
companies
in the Software industry
Industry Median: 0.19
vs XPAR:NRO: 0.09
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Neurones Debt-to-Equity Related Terms
Neurones Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Neurones's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:NRO vs IBM, ACN, FISV: Debt-to-Equity Comparison
For the Information Technology Services subindustry, Neurones's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurones Debt-to-Equity vs Software Industry
For the Software industry and Technology sector, Neurones's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Neurones's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neurones (XPAR:NRO) has a Debt-to-Equity of 0.09 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Neurones and its competitors. This is 18% below median its historical median of 0.11. According to the industry distribution chart, Neurones ranks #734 out of 2246 companies in the Software industry, placing it in the top 32.7%.
Is Neurones' Debt-to-Equity too high?
Neurones' current Debt-to-Equity of 0.09 is 18% below median its 10-year median of 0.11. The Software industry median Debt-to-Equity is 0.19. Neurones' value of 0.09 is 52.6% below this industry median. Based on the distribution chart, Neurones ranks #734 out of 2246 companies in the Software industry, which is above the industry midpoint. Overall, Neurones has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' Debt-to-Equity compare to IBM and ACN?
According to the Software industry distribution chart, Neurones ranks #734 out of 2246 companies for Debt-to-Equity. This puts Neurones in the upper half of its industry. The industry median Debt-to-Equity is 0.19. Neurones' value of 0.09 is 52.6% below this benchmark. While the company's 10-year median is 0.11 vs. the industry median of 0.19, Neurones has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Software company?
The median Debt-to-Equity among Software companies is 0.19, based on 2,246 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neurones's current Debt-to-Equity of 0.09 is 52.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Neurones and its competitors. For the Software industry, the median Debt-to-Equity is 0.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neurones's current Debt-to-Equity is 0.09, which is 18% below median its own 10-year median of 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Modestly Undervalued. The stock's GF Value™ is €50.62, compared to a current price of €38.00 — trading 24.9% below its estimated fair value. The current Debt-to-Equity is 0.09, which is 18% below median its 10-year median of 0.11 and 52.6% below the Software industry median of 0.19. Neurones' overall GF Score™ is 98/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current Debt-to-Equity is 0.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neurones (XPAR:NRO) Overvalued in 2026?
Based on GuruFocus' analysis, Neurones stock appears to be undervalued.
The current stock price of €38.00 is trading 24.9% below its estimated GF Value™ of €50.62.
GuruFocus considers Neurones to be Modestly Undervalued.
Key valuation signals for XPAR:NRO:
Debt-to-Equity: 0.09 (18% below median its 10-year median of 0.11)
GF Value™: €50.62 vs. price of €38.00 (24.9% below fair value)
Industry Position: 52.6% below the Software median (#734 of 2246)
No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
98GF Score
Get the complete analysis for XPAR:NRO
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:NRO has been successfully added to your 
